Enlivex
Chen Ankri (PhD) is a highly experienced professional in the field of pharmacology and immunology, currently serving as Director of Pre Clinical and Clinical Pharmacology and Head of Pre Clinical and Clinical Pharmacology at Enlivex Therapeutics since June 2020. Prior to this role, Chen held the position of Projects Manager at the same company and worked as Immunology Manager at CTG Pharma from March 2018 to June 2020. Chen's career began as a Senior Research Scientist in Cancer Immunology at Curetec Ltd and included valuable experience as a Ph.D. student and Teaching Assistant at Bar-Ilan University, focusing on cancer immunology and immunotherapy. Additionally, Chen gained clinical research experience as a Student Research Assistant at Sheba - Tel Ha SHomer Hospital. Chen Ankri holds a Bachelor's Degree in Biotechnology from Bar-Ilan University.
This person is not in any offices
Enlivex
Enlivex's mission is to establish new equilibriums – both in patients’ immune responses and in the field of immunotherapy. As a clinical-stage company focused on specialized cell immunotherapy, Enlivex intends to develop and commercialize an allogeneic drug pipeline for rebalancing all manner of immune hyper-responses.